Qulab Applies Artificial Intelligence To Drug Design
socalTECH
APRIL 24, 2019
The startup--backed by Cota Capital, Civilization Ventures, Plug and Play, and 415--says that Quleap automated small molecule, synthesis planning, and a cloud engine for simulating biomolecules. He also attended USC's Viterbi School of Engineering as a Ph.D. READ MORE>>.
Let's personalize your content